Loading news...
GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.
GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that it has completed the acquisition of Intelerad, a leading medical imaging software provider for the healthcare industry, for a base purchase price of $2.3 billion in cash (subject to customary adjustments). Intelerad's technology and customer base will extend GE HealthCare's reach into high-growth specialized clinics and ambulatory care environments, complementing the company's strength in hospital-based imaging. These combined capabil.
Avity Investment Management Inc. lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 91.6% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,300 shares of the company's stock after selling 112,745 shares during the quarter. Avity Investment Management
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE: SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities.
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Alliancebernstein L.P. trimmed its stake in GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 16.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,303,149 shares of the company's stock after selling 869,244 shares during the quarter. Alliancebernstein L.P. owned approximately 0.94% of GE
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GE HealthCare (GEHC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GE HealthCare wins FDA 510(k) clearance for View, a cloud-native imaging viewer in Genesis Radiology Workspace aimed at improving radiology workflows.
GE HealthCare Technologies Inc. (GEHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that View, the powerful viewer within the Genesis™ Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis Radiology Workspace.2 This next‑generation solution aims to transform radiology workflows, unify the user experience, and empower radiologists with greater efficiency and precision. Studies.
Barclays PLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 10.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,753,314 shares of the company's stock after purchasing an additional 164,821 shares during the
LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition 2026 in Las Vegas from March 9-12, 2026. This year, GE HealthCare will spotlight meaningful technology transforming the way healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound, and patient care technologies.
/PRNewswire/ -- USANewsGroup.com News Commentary - AI is making its way through the halls of our entire medical system, and the implementation is accelerating
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GE HealthCare inks a 10-year Care Alliance with UCSF Health to expand advanced imaging, boost MR excellence and strengthen long-term revenue visibility.
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
GE HealthCare Technologies Inc. (GEHC) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
GE HealthCare unveils next-gen LOGIQ ultrasound systems with AI and Verisound Digital tech, targeting liver disease and faster workflows to boost diagnostic precision.